Alnylam Pharmaceuticals
ALNY
#601
Rank
S$44.30 B
Marketcap
$343.47
Share price
4.37%
Change (1 day)
37.33%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

Market capitalization of Alnylam Pharmaceuticals (ALNY)

Market cap: S$44.30 Billion

As of January 2025 Alnylam Pharmaceuticals has a market cap of S$44.30 Billion. This makes Alnylam Pharmaceuticals the world's 601th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Alnylam Pharmaceuticals from 2004 to 2025

End of year Market Cap

Year Marketcap Change
2025S$44.30 B6.19%
2024S$41.72 B31.51%
2023S$31.72 B-19.06%
2022S$39.19 B42.95%
2021S$27.41 B37.26%
2020S$19.97 B14.68%
2019S$17.41 B72.85%
2018S$10.07 B-40.2%
2017S$16.85 B262.41%
2016S$4.64 B-58.96%
2015S$11.33 B14.51%
2014S$9.89 B90.55%
2013S$5.19 B343.28%
2012S$1.17 B159.77%
2011S$0.45 B-16.15%
2010S$0.53 B-48.03%
2009S$1.03 B-29.34%
2008S$1.46 B-14.16%
2007S$1.70 B40.33%
2006S$1.21 B183.44%
2005S$0.42 B82.53%
2004S$0.23 B

End of Day market cap according to different sources

On Jan 15th, 2025 the market cap of Alnylam Pharmaceuticals was reported to be:

S$44.30 Billion
by Yahoo Finance info icon info icon
S$44.30 Billion
by CompaniesMarketCap info icon info icon
S$44.30 Billion
by Nasdaq info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
S$3.22 B-92.72%๐Ÿ‡บ๐Ÿ‡ธ USA
S$105.77 B 138.76%๐Ÿ‡บ๐Ÿ‡ธ USA
S$15.59 B-64.79%๐Ÿ‡บ๐Ÿ‡ธ USA
S$1.35 B-96.95%๐Ÿ‡บ๐Ÿ‡ธ USA
S$0.11 B-99.74%๐Ÿ‡บ๐Ÿ‡ธ USA
S$271.53 B 512.92%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
S$169.37 B 282.32%๐Ÿ‡ซ๐Ÿ‡ท France
S$34.01 B-23.22%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel